Journal
ONCOGENE
Volume 29, Issue 34, Pages 4752-4765Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.221
Keywords
DR4; DR5; glycosylation; caspase-8; cullin 3; p62
Ask authors/readers for more resources
Apoptosis ligand 2 tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL) belongs to a small subset of proapoptotic protein ligands in the TNF superfamily. This subset, which also includes Fas ligand and TNF-alpha, can activate the extrinsic apoptotic cell death pathway on binding to cognate death receptors at the cell surface. Over the past 10 years, Apo2L/TRAIL has emerged as a promising candidate for cancer therapy, on the basis of its unique ability to trigger apoptosis in various types of cancer cells without significant toxicity toward normal cells. Herein, we review key advances in understanding the molecular events that control apoptosis signaling by Apo2L/TRAIL, which may aid in the development of cancer therapies based on the extrinsic apoptotic pathway. Oncogene (2010) 29, 4752-4765; doi:10.1038/onc.2010.221; published online 7 June 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available